Soft tissue

Targeted testing for improved patient management

Sarcoma can occur in any of the soft tissue in the body, as well as bones, and is the fourth most common type of pediatric cancer.1 Because there are more than 100 subtypes of sarcoma, many with overlapping features, genetic testing can clarify and improve diagnostic accuracy and overall patient management.

SOFT TISSUE test menu

Soft tissue

Our sarcoma fusion panel assesses for fusions described in 39 subtypes of soft tissue, bone, and other mesenchymal tumors. Because fusion events can occur between known or novel gene partners, the panel is designed to provide the most comprehensive analysis by including 124 gene fusion pairs, 274 fusion variants, and novel gene partner detection.

Key testing

Advantages

  • Analyzes rearrangements for 138 genes including known and novel fusions.
  • Assesses fusions described in 39 subtypes of soft tissue and bone tumors.
  • Includes fusions common in pediatric rhabdomyosarcoma and Ewing sarcoma family and related tumors.

References
  1. Williams R,  Fernandez-Pineda I,  Gosain A. Pediatric Sarcomas. The Surgical Clinics of North America 2016-10-01, Volume 96, Issue 5, Pages 1107-1125. 
INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.

(BETA) Choose a language to view this content in:
About the translation.